Status:
RECRUITING
Cancer-associated Cachexia in Patients With Incurable Gastroesophageal Cancer
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Gastro-Esophageal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
Patients with incurable gastroesophageal cancer are at high risk of cancer cachexia with an estimated prevalence of 60-80%. Cancer cachexia is defined as ongoing loss of skeletal muscle mass with or w...
Eligibility Criteria
Inclusion
- Patients eligible for participation are any patient diagnosed with histologically verified, incurable cancer of the esophagus, stomach, or gastroesophageal junction, referred to first line chemotherapy.
Exclusion
- Age \< 18 years
Key Trial Info
Start Date :
May 10 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2028
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06137508
Start Date
May 10 2024
End Date
December 1 2028
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Denmark